His primary areas of investigation include Immunology, Tumor necrosis factor alpha, Cerebral Malaria, Cytokine and Necrosis. His work on Immunology is being expanded to include thematically relevant topics such as In vitro. Georges E. Grau has included themes like Lesion, Pathology, Macrophage and In vivo in his Tumor necrosis factor alpha study.
His Cerebral Malaria study frequently intersects with other fields, such as Plasmodium berghei. His Cytokine research is multidisciplinary, incorporating perspectives in Molecular biology and Blood plasma. His study looks at the intersection of Necrosis and topics like Interleukin 3 with Anti-CD3 monoclonal antibody and Interleukin 2.
His primary scientific interests are in Immunology, Tumor necrosis factor alpha, Cerebral Malaria, Pathology and Malaria. His work in Immunology addresses subjects such as Endothelium, which are connected to disciplines such as Endothelial stem cell. The concepts of his Tumor necrosis factor alpha study are interwoven with issues in Cytokine, Receptor, Molecular biology, Necrosis and In vivo.
His Cytokine research is multidisciplinary, relying on both T cell and Cell adhesion molecule. His studies in Cerebral Malaria integrate themes in fields like Parasitemia, Blood–brain barrier and Plasmodium berghei. His Malaria study combines topics in areas such as Anemia, Immunopathology and Virology.
Georges E. Grau spends much of his time researching Immunology, Cerebral Malaria, Pathogenesis, Cell biology and Malaria. His biological study spans a wide range of topics, including Coinfection, Platelet, Therapeutic approach and Plasmodium berghei. His Pathogenesis research is included under the broader classification of Pathology.
His Cell biology study incorporates themes from Tumor necrosis factor alpha, Endothelial stem cell, Angiogenesis, microRNA and Endothelium. While the research belongs to areas of Tumor necrosis factor alpha, Georges E. Grau spends his time largely on the problem of Endosome, intersecting his research to questions surrounding Annexin. His Malaria research integrates issues from Receptor, Deficient mouse, Signalling and Urokinase.
Georges E. Grau mainly investigates Immunology, Pathogenesis, Cerebral Malaria, Cell biology and Malaria. Georges E. Grau has researched Immunology in several fields, including Endothelium and Lung injury. His biological study spans a wide range of topics, including Interleukin 33 and Epithelium.
His research in Cerebral Malaria tackles topics such as Platelet which are related to areas like Parasitemia and Blood–brain barrier. His Malaria research focuses on Immunopathology and how it connects with Parasite Infections, Interferon gamma, Innate immune system, Cytokine and Immunity. Georges E. Grau has included themes like Tumor necrosis factor alpha, Binding site and Vascular permeability in his Endothelial stem cell study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
Vincent Kindler;André-Pascal Sappino;Georges E. Grau;Pierre-François Piguet.
Cell (1989)
DIAGNOSTIC VALUE OF PROCALCITONIN, INTERLEUKIN-6, AND INTERLEUKIN-8 IN CRITICALLY ILL PATIENTS ADMITTED WITH SUSPECTED SEPSIS
Stephan Harbarth;Katarina Holeckova;Céline Froidevaux;Didier Pittet.
American Journal of Respiratory and Critical Care Medicine (2001)
Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria
Georges E. Grau;Terrie E. Taylor;Malcolm E. Molyneux;Jack J. Wirima.
The New England Journal of Medicine (1989)
Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.
Georges E. Grau;Luis F. Fajardo;Pierre-Francois Piguet;Bernard Allet.
Science (1987)
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
Eric Girardin;Georges E. Grau;Jean-Michel Dayer;Pascale Roux-Lombard.
The New England Journal of Medicine (1988)
Immunological processes in malaria pathogenesis.
Louis Schofield;Georges E. R. Grau.
Nature Reviews Immunology (2005)
Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
P F Piguet;G E Grau;B Allet;P Vassalli.
Journal of Experimental Medicine (1987)
High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis.
Peter M. Suter;Susanne Suter;Eric Girardin;Pascale Roux-Lombard.
The American review of respiratory disease (1992)
Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis
Pierre F. Piguet;Martine A. Collart;Georges E. Grau;André-P. Sappino.
Nature (1990)
Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock
Thierry Calandra;Jean-Daniel Baumgartner;Georges E. Grau;Mei-Miau Wu.
The Journal of Infectious Diseases (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Sydney
University of Geneva
University of Geneva
Liverpool School of Tropical Medicine
Université Paris Cité
Nanyang Technological University
Inserm : Institut national de la santé et de la recherche médicale
Michigan State University
University of Pennsylvania
University of Sydney
University of Calgary
Stanford University
Chalmers University of Technology
Georgetown University
University of New Mexico
Virginia Tech
Johns Hopkins University
Cincinnati Children's Hospital Medical Center
Tokyo Medical University
CSIRO Ocean and Atmosphere
The University of Texas at Dallas
Florida State University
University of Perugia
University of Hong Kong
Boston University
Queen Mary University of London